We are live on ! Find out more
ONXX

ONYX PHARMACEUTICALS INC
ONXX

Delisted

ONXX was delisted on the 30th of September, 2013.

Back to rankings

0 hedge funds and large institutions have $0 invested in ONYX PHARMACEUTICALS INC in 2013 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 257 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 258 → 0 (-258)

100% less funds holding in top 10

Funds holding in top 10: 46 → 0 (-46)

100% less capital invested

Capital invested by funds: $7.38B → $0 (-$7.38B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 257

Holders
–
Holders Change
-258
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-46
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
257
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$512M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$421M
3
DKCM
Davidson Kempner Capital Management
New York
-$393M
4
HI
HBK Investments
Texas
-$339M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$259M
Name Holding Trade Value Shares
Change 		Change in
Stake
FFH
201
Fairfax Financial Holdings
Ontario, Canada
– -$561K -4,500 Closed
TD Asset Management
202
TD Asset Management
Ontario, Canada
– -$536K -4,300 Closed
CBOA
203
Commonwealth Bank of Australia
Australia
– -$524K -4,200 Closed
SM
204
Sabby Management
Florida
– -$504K -4,045 Closed
Zurich Cantonal Bank
205
Zurich Cantonal Bank
Switzerland
– -$476K -3,819 Closed
PAM
206
Panagora Asset Management
Massachusetts
– -$461K -3,700 Closed
SCM
207
Stux Capital Management
New York
– -$449K -3,600 Closed
CAN
208
Cetera Advisor Networks
California
– -$446K -3,582 Closed
WBC
209
Westpac Banking Corp
Australia
– -$411K -3,300 Closed
Baillie Gifford & Co
210
Baillie Gifford & Co
United Kingdom
– -$384K -3,079 Closed
JCM
211
JD Capital Management
Connecticut
– -$374K -3,000 Closed
Manulife (Manufacturers Life Insurance)
212
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$352 -2,822 Closed
AAM
213
Advisors Asset Management
Colorado
– -$346K -2,773 Closed
Jane Street
214
Jane Street
New York
– -$324K -2,600 Closed
AA
215
Ancora Advisors
Ohio
– -$299K -2,400 Closed
Citadel Advisors
216
Citadel Advisors
Florida
– -$291K -2,340 Closed
AIG
217
American International Group
New York
– -$291K -2,338 Closed
ICAS
218
Investors Capital Advisory Services
Massachusetts
– -$280K -2,250 Closed
DILH
219
Dai-ichi Life Holdings
Japan
– -$275K -2,207 Closed
QI
220
QS Investors
New York
– -$273K -2,200 Closed
Verition Fund Management
221
Verition Fund Management
Connecticut
– -$270K -2,168 Closed
CCA
222
Catalyst Capital Advisors
New York
– -$249K -2,000 Closed
Creative Planning
223
Creative Planning
Kansas
– -$241K -1,935 Closed
EOJOAM
224
E. Ohman J:or Asset Management
Sweden
– -$237K -1,900 Closed
Fifth Third Bancorp
225
Fifth Third Bancorp
Ohio
– -$235K -1,882 Closed
7 8
9
10 11

ONXX Hedge Fund Activity: Q4 2013 in Review

0 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in ONYX PHARMACEUTICALS INC (ONXX) for Q4 2013, worth a combined $0 — down 100% from $7.38B a quarter earlier.

Sellers outnumbered buyers: 257 funds closed out of ONXX and 0 opened new positions — a net loss of 257 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Adage Capital Partners, exiting entirely with an estimated $512M sold.

  • 0 institutional investors held ONYX PHARMACEUTICALS INC (ONXX) as of Q4 2013, down from 258 in Q3 2013.
  • Funds reported $0 of ONYX PHARMACEUTICALS INC stock for Q4 2013, down 100% quarter-over-quarter.
  • 0 funds opened new ONYX PHARMACEUTICALS INC positions in Q4 2013 and 257 closed out, a net change of -257 holders.
  • The largest ONYX PHARMACEUTICALS INC seller in Q4 2013 was Adage Capital Partners, an estimated $512M sold.

Based on aggregated 13F filings for Q4 2013.